PAA Members
Member Login
 

PAA Insider

As a PAA member, you have full access to the Member Newsletter.

  • On March 12, the FDA approved an expanded age indication for AREXVY to include adults aged 18-49 years at increased risk for RSV-LRTD. The FDA also added a limitation of use that AREXVY is not for use in pregnant individuals. Log in to read the......

  • Sanofi invites you to attend this complimentary 60-minute webinar on coding, coverage, and reimbursement for Flublok® (Influenza Vaccine), Fluzone® High-Dose (Influenza Vaccine), Fluzone® (Influenza Vaccine), Beyfortus® (nirsevimab-alip) and Nuvaxovi...

  • AbbVie announced that the 2026 Wholesale Acquisition Cost of the Liletta IUD has increased as of January 1st. However, there will be no price increase for PAA members until April 1, 2026. PAA members can order Liletta at the current contract price un...

  • GSK has announced that PAA vaccine contract pricing will change effective 2/1/2026. Also as GSK transitions to Shingrix prefilled syringes on 2/2/2026, they have provided the important information for members regarding availability. Log in to the mem...

  • Sanofi and Pfizer have announced that PAA vaccine contract pricing will change effective 1/1/2026. Members can log in to view the price changes....

  • We are excited to announce major improvements to our Vaccine Rebate Program! We are increasing our members’ rebate potential and decreasing the thresholds to qualify. Sign in to our member site to view details. The PAA Vaccine Rebate Program has sent...

  • Pfizer invites you to attend an informative webinar that will provide an overview of billing and coding information for ABRYSVO maternal RSV vaccination, including relevant codes, documentation requirements, and reimbursement information. This sessio...

  • Learn about compelling data for infant RSV immunization to support your immunization efforts for the 2025–2026 RSV season. Sanofi invites you to attend this session which will focus on Beyfortus® (nirsevimab-alip) 50mg and 100mg and how to effectivel...

  • GSK announces an expanded indication for Arexvy, and invites PAA members to register for their RSV Awareness Webinar Series, The Risk of Respiratory Syncytial Virus (RSV): Disease Burden and Vaccination. Log in to learn more and to register....

  • Moderna has recently announced an expanded indication for mResvia. PAA members are also invited to attend an upcoming webinar hosted by Moderna, “Introducing Moderna’s Recently Approved mNEXSPIKE (COVID-19 Vaccine, mRNA)”. Members can log...

  • GSK has announced that the contract price for Bexsero (MenB vaccine) has been reduced effective 7/1/2025. Log in to see current GSK pricing and webinar opportunities....

  • Pfizer has announced pricing updates effective 7/1/2025. Log in to learn more.  PAA is also pleased to announce that we have recently signed a new contract with Pfizer, effective July 1st. This new agreement introduces two pricing programs designed t...

  • Pfizer reminds members that as the back-to-school immunization season approaches please be aware that after the October 2024 ACIP meeting, all MenB vaccines now align to the same recommended schedule (2 doses at 0 and 6 months when used as a 2-dose s...

  • PAA’s agreement with AbbVie not only provides best pricing on the Liletta IUD, but also allows practices to place orders of any size with no minimums. Members can try the Liletta IUD without the commitment of minimum orders....

  • Well known for vaccine savings and rebates, Physicians’ Alliance also partners with the below trusted vendors offering additional ways to save your practice money. From clearinghouse service with Trizetto, practice communications with POS and p...

  • Seqirus has announced that the seasonal returns window for its Influenza Vaccine Product is now open. Request the required Return Authorization labels no later than June 15th. Log in to learn more....

  • Pre-booking for the 2025-26 flu season is coming to an end. GSK’s pre-book deadline has passed, but we have been advised that members have the ability to procure flu vaccine until 4/25/25. Seqirus also announced their pre-book deadline has been...

  • GSK has announced that the contract price for Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) will change effective 5/15/2025. Read details by logging in to the member site....

  • Moderna has announced the seasonal returns window for its COVID-19 Vaccine Product is April 1st through August 31st, PAA members who purchased through our Moderna agreement may return eligible vaccines starting April 1st. Log in now to find out more ...

  • Merck announced last month that their pediatric hepatitis B vaccine will not be available until early 2018. The CDC and the American Academy of Pediatrics recommend routine vaccination for all newborns against hepatitis B, a liver infection transmitt...